The Zhitong Finance App learned that according to the Hong Kong Stock Exchange's disclosure on August 28, FronteraTherapeutics (Frontera for short) submitted a listing application to the main board of the Hong Kong Stock Exchange, with UBS Group and Haitong International as co-sponsors. The company first submitted a statement on December 23, 2025.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.